Substance Use

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

More anxiety symptoms were associated with greater frequency of poly-substance use over time in adolescents and young adults at high risk for smoking escalation, with effects moderated by gender (sign

Effect: decline; beta = .04, t(7726) = 3.57

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34

Weaker negative mood regulation expectancies (lower belief in ability to alter negative moods) were associated with greater poly-substance use over time, specifically associated with more marijuana an

Effect: decline; beta = -.04, t(7726) = -3.34